The Burden of Uterine Fibroids for African-American Women: Results of a National Survey

Overview

Journal J Womens Health (Larchmt)

Specialty Gynecology & Obstetrics

Date 2013 Sep 17

PMID 24033092

Citations 80

Authors

Elizabeth A Stewart

Wanda K Nicholson

Linda Bradley

Bijan J Borah

Affiliations

Soon will be listed here.

Abstract

Background: Uterine fibroids have a disproportionate impact on African-American women. There are, however, no data to compare racial differences in symptoms, quality of life, effect on employment, and information-seeking behavior for this disease.

Methods: An online survey was conducted by Harris Interactive between December 1, 2011 and January 16, 2012. Participants were U.S. women aged 29-59 with symptomatic uterine fibroids. African-American women were oversampled to allow statistical comparison of this high-risk group. Bivariate comparison of continuous and categorical measures was based on the t-test and the Chi-squared test, respectively. Multivariable adjustment of risk ratios was based on log binomial regression.

Results: The survey was completed by 268 African-American and 573 white women. There were no differences between groups in education, employment status, or overall health status. African-American women were significantly more likely to have severe or very severe symptoms, including heavy or prolonged menses (RR=1.51, 95% CI 1.05-2.18) and anemia (RR=2.73, 95% CI 1.47-5.09). They also more often reported that fibroids interfered with physical activities (RR=1.67, 95% CI 1.20-2.32) and relationships (RR=2.27, 95% CI 1.23-4.22) and were more likely to miss days from work (RR=1.77, 95% CI 1.20-2.61). African-American women were more likely to consult friends and family (36 vs. 22%, P=0.004) and health brochures (32 vs. 18%, P<0.001) for health information. Concerns for future fertility (RR=2.65, 95% CI 1.93-3.63) and pregnancy (RR=2.89, 95% CI 2.11-3.97) following fibroid treatments were key concerns for black women.

Conclusions: African-American women have more severe symptoms, unique concerns, and different information-seeking behavior for fibroids.

Citing Articles

A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding.

Wang X, Li J, Liu Y, Zheng Y, Wang X, Liu G Gland Surg. 2025; 14(1):60-73.

PMID: 39958902 PMC: 11826254. DOI: 10.21037/gs-24-386.

Navigating diagnostic challenges: case reports on differentiating uterine fibroids from leiomyosarcoma through imaging and clinical evaluation.

Algeri P, Adorni M, Besana G, Carlini L, Ciammella M, Garbo S J Ultrasound. 2025; .

PMID: 39904952 DOI: 10.1007/s40477-025-00991-3.

Uterine fibroids show evidence of shared genetic architecture with blood pressure traits.

Akerele A, Piekos J, Kim J, Khankari N, Hellwege J, Edwards T Pac Symp Biocomput. 2024; 30:281-295.

PMID: 39670377 PMC: 11649017.

Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid database.

Agarwal S, Stokes M, Chen R, Lickert C AJOG Glob Rep. 2024; 4(4):100412.

PMID: 39559275 PMC: 11570315. DOI: 10.1016/j.xagr.2024.100412.

The role of socioeconomic status in uterine fibroid awareness and treatment: a narrative review.

Evans J, Jones K Ther Adv Reprod Health. 2024; 18:26334941241297634.

PMID: 39525322 PMC: 11550501. DOI: 10.1177/26334941241297634.

References

Lee D, Ozminkowski R, Carls G, Wang S, Gibson T, Stewart E . The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids. J Occup Environ Med. 2007; 49(5):493-506. DOI: 10.1097/JOM.0b013e31805f6cf2. View

Bouwsma E, Hesley G, Woodrum D, Weaver A, Leppert P, Peterson L . Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial. Fertil Steril. 2011; 96(3):704-10. PMC: 3165063. DOI: 10.1016/j.fertnstert.2011.06.062. View

LaRocca N . Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011; 4(3):189-201. DOI: 10.2165/11591150-000000000-00000. View

Huyck K, Panhuysen C, Cuenco K, Zhang J, Goldhammer H, Jones E . The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol. 2008; 198(2):168.e1-9. PMC: 2265083. DOI: 10.1016/j.ajog.2007.05.038. View

Groff J, Mullen P, Byrd T, Shelton A, Lees E, Goode J . Decision making, beliefs, and attitudes toward hysterectomy: a focus group study with medically underserved women in Texas. J Womens Health Gend Based Med. 2000; 9 Suppl 2:S39-50. DOI: 10.1089/152460900318759. View

Baird D, Dunson D, Hill M, Cousins D, Schectman J . High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003; 188(1):100-7. DOI: 10.1067/mob.2003.99. View

Powell L, Meyer P, Weiss G, Matthews K, Santoro N, Randolph Jr J . Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues. 2005; 15(4):179-86. DOI: 10.1016/j.whi.2005.05.002. View

Moss J, Cooper K, Khaund A, Murray L, Murray G, Wu O . Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG. 2011; 118(8):936-44. DOI: 10.1111/j.1471-0528.2011.02952.x. View

Merrill R . Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2007; 14(1):CR24-31. View

10.

Gross K, Panhuysen C, Kleinman M, Goldhammer H, Jones E, Nassery N . Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies. Genes Chromosomes Cancer. 2004; 41(3):183-90. DOI: 10.1002/gcc.20079. View

11.

Stewart E, Shuster L, Rocca W . Reassessing hysterectomy. Minn Med. 2012; 95(3):36-9. PMC: 3804006. View

12.

Zhao S, Wong J, Arguelles L . Hospitalization costs associated with leiomyoma. Clin Ther. 1999; 21(3):563-75. DOI: 10.1016/S0149-2918(00)88309-5. View

13.

Montes G, Lotyczewski B, Halterman J, Hightower A . School readiness among children with behavior problems at entrance into kindergarten: results from a US national study. Eur J Pediatr. 2011; 171(3):541-8. DOI: 10.1007/s00431-011-1605-4. View

14.

Hartmann K, Birnbaum H, Ben-Hamadi R, Wu E, Farrell M, Spalding J . Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006; 108(4):930-7. DOI: 10.1097/01.AOG.0000234651.41000.58. View

15.

Harlow B, Barbieri R . Influence of education on risk of hysterectomy before age 45 years. Am J Epidemiol. 1999; 150(8):843-7. DOI: 10.1093/oxfordjournals.aje.a010089. View

16.

Spies J, Coyne K, Guaou N, Boyle D, Gonzalves S . The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002; 99(2):290-300. DOI: 10.1016/s0029-7844(01)01702-1. View

17.

Wechter M, Stewart E, Myers E, Kho R, Wu J . Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends. Am J Obstet Gynecol. 2011; 205(5):492.e1-5. PMC: 3746963. DOI: 10.1016/j.ajog.2011.07.008. View

18.

Lee D, Gibson T, Carls G, Ozminkowski R, Wang S, Stewart E . Uterine fibroid treatment patterns in a population of insured women. Fertil Steril. 2008; 91(2):566-74. DOI: 10.1016/j.fertnstert.2007.12.004. View

19.

Stewart E . Uterine fibroids and evidence-based medicine--not an oxymoron. N Engl J Med. 2012; 366(5):471-3. DOI: 10.1056/NEJMe1114043. View

20.

Baird D, Hill M, Schectman J, Hollis B . Vitamin d and the risk of uterine fibroids. Epidemiology. 2013; 24(3):447-53. PMC: 5330388. DOI: 10.1097/EDE.0b013e31828acca0. View